4D Molecular Therapeutics
5858 Horton St. Suite 455,
Emeryville, 94608, CA,
United States
Emeryville, 94608, CA,
United States
1 510-505-2680
Life Sciences
4D Molecular Therapeutics Technographics
4D Molecular Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by 4D Molecular Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 147 4D Molecular Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that 4D Molecular Therapeutics has purchased the following applications: Lever by Employ for Applicant Tracking System in 2019, Sapio LIMS for Laboratory Management in 2022, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems 4D Molecular Therapeutics is running and its propensity to invest more and deepen its relationship with Employ , Sapio Sciences , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing 4D Molecular Therapeutics revenues, which have grown to $20.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for 4D Molecular Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
4D Molecular Therapeutics Tech Stack and Enterprise Applications
4D Molecular Therapeutics HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Employ | Legacy | Lever by Employ | Applicant Tracking System | HCM | n/a | 2019 | 2019 |
In 2019, 4D Molecular Therapeutics implemented Lever by Employ as their Applicant Tracking System. The Lever by Employ implementation is embedded on the company's public careers site to capture candidate applications and centralize recruiting data. This positions Lever by Employ Applicant Tracking System as the company's primary system for talent acquisition and applicant lifecycle management.
Configuration emphasizes core Applicant Tracking System modules including candidate sourcing and intake, job posting and requisition management, applicant tracking with pipeline visualization, interview scheduling, and offer tracking. Automation rules were applied to standardize candidate routing and status transitions, and candidate profile consolidation was configured to support scientific hiring workflows. Reporting and basic analytics capabilities are used to provide hiring funnel visibility for Talent Acquisition.
The deployment follows a cloud hosted SaaS model and integrates directly with the public careers site to manage application intake and candidate routing. Operational ownership is within Talent Acquisition and HR, covering recruiting workflows and candidate data governance across the organization. Governance changes included formalizing hiring workflows, pipeline ownership, and data handling processes to align recruiting activities with corporate compliance and hiring policies.
|
4D Molecular Therapeutics ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Sapio Sciences | Legacy | Sapio LIMS | Laboratory Management | ERP Services and Operations | n/a | 2022 | 2022 |
In 2022, 4D Molecular Therapeutics implemented Sapio LIMS to support Supply Chain functions. The Sapio LIMS deployment targeted Laboratory Management workflows and was positioned to instrument clinical supply and CMC interfaces across the organization.
The Sapio LIMS implementation was configured to address core Laboratory Management capabilities, including inventory management, sample and kit tracking, pack and label workflows, and depot activity orchestration. Configuration emphasized chain of custody records and audit-ready documentation to support clinical program material handling and traceability.
Operational scope covered Supply Chain and CMC support for five clinical programs, with direct oversight of depot activities to ensure pack and label tasks met program needs. The deployment was planned and executed with supply chain ownership for Trial Master File filing needs and included forward-looking improvement planning for broader process adoption.
Governance and process workstreams included establishing TMF filing ownership on behalf of CMC, conducting a gap assessment between early clinical practices and later phase EU compliance, and planning actionable items to bridge those gaps with minimal supervision. Sapio LIMS serves as the Laboratory Management application centralizing supply chain workflows, pack and label operations, and clinical material governance across affected business functions.
|
4D Molecular Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, 4D Molecular Therapeutics implemented DocuSign eSignature as a Digital Signing solution. DocuSign eSignature is embedded on the company website to capture legally binding electronic signatures for external document workflows and web initiated agreements, establishing an online signing channel directly on public-facing pages.
The implementation leverages core DocuSign eSignature capabilities typical of the Digital Signing category, including envelope and signature workflow orchestration, reusable templates, embedded signing flows, signer authentication and comprehensive audit trails. Governance is concentrated on document templates and signer authentication controls to centralize signature policy and streamline contract execution and other external document processes, with the website integration serving as the operational touchpoint for external parties.
|
4D Molecular Therapeutics ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IT Service Management | ITSM |
|
2021 | 2021 |
|
|
|
|
|
IT Service Management | ITSM |
|
2023 | 2023 |
|
4D Molecular Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
4D Molecular Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at 4D Molecular Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by 4D Molecular Therapeutics Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from 4D Molecular Therapeutics IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the 4D Molecular Therapeutics digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD 4D Molecular Therapeutics Technographics
4D Molecular Therapeutics is a Life Sciences organization based in United States,
with around 147 employees and annual revenues of $20.0 million.
4D Molecular Therapeutics operates a diverse technology stack with applications such as
Lever by Employ, Sapio LIMS and DocuSign eSignature,
covering areas like Applicant Tracking System, Laboratory Management and Digital Signing.
4D Molecular Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Employ, Sapio Sciences and DocuSign.
4D Molecular Therapeutics recently adopted applications including
ServiceNow ITSM in 2023, Sapio LIMS in 2022 and Cloudflare CDN in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of 4D Molecular Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates 4D Molecular Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete 4D Molecular Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.